931 related articles for article (PubMed ID: 32217751)
1. Unconstrained genome targeting with near-PAMless engineered CRISPR-Cas9 variants.
Walton RT; Christie KA; Whittaker MN; Kleinstiver BP
Science; 2020 Apr; 368(6488):290-296. PubMed ID: 32217751
[TBL] [Abstract][Full Text] [Related]
2. SpRY Cas9 Can Utilize a Variety of Protospacer Adjacent Motif Site Sequences To Edit the Candida albicans Genome.
Evans BA; Bernstein DA
mSphere; 2021 May; 6(3):. PubMed ID: 34011687
[No Abstract] [Full Text] [Related]
3. Unraveling the mechanisms of PAMless DNA interrogation by SpRY-Cas9.
Hibshman GN; Bravo JPK; Hooper MM; Dangerfield TL; Zhang H; Finkelstein IJ; Johnson KA; Taylor DW
Nat Commun; 2024 Apr; 15(1):3663. PubMed ID: 38688943
[TBL] [Abstract][Full Text] [Related]
4. PAMless SpRY exhibits a preference for the seed region for efficient targeting.
Yang C; Zhou Z; Sun X; Ju H; Yue X; Rao S; Xue C
Cell Rep; 2024 May; 43(5):114225. PubMed ID: 38733582
[TBL] [Abstract][Full Text] [Related]
5. The SpRY Cas9 variant release the PAM sequence constraint for genome editing in the model plant Physcomitrium patens.
Calbry J; Goudounet G; Charlot F; Guyon-Debast A; Perroud PF; Nogué F
Transgenic Res; 2024 Apr; 33(1-2):67-74. PubMed ID: 38573428
[TBL] [Abstract][Full Text] [Related]
6. Developing Heritable Mutations in Arabidopsis thaliana Using a Modified CRISPR/Cas9 Toolkit Comprising PAM-Altered Cas9 Variants and gRNAs.
Yamamoto A; Ishida T; Yoshimura M; Kimura Y; Sawa S
Plant Cell Physiol; 2019 Oct; 60(10):2255-2262. PubMed ID: 31198958
[TBL] [Abstract][Full Text] [Related]
7. Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes.
Vicencio J; Sánchez-Bolaños C; Moreno-Sánchez I; Brena D; Vejnar CE; Kukhtar D; Ruiz-López M; Cots-Ponjoan M; Rubio A; Melero NR; Crespo-Cuadrado J; Carolis C; Pérez-Pulido AJ; Giráldez AJ; Kleinstiver BP; Cerón J; Moreno-Mateos MA
Nat Commun; 2022 May; 13(1):2601. PubMed ID: 35552388
[TBL] [Abstract][Full Text] [Related]
8. Improving Plant Genome Editing with High-Fidelity xCas9 and Non-canonical PAM-Targeting Cas9-NG.
Zhong Z; Sretenovic S; Ren Q; Yang L; Bao Y; Qi C; Yuan M; He Y; Liu S; Liu X; Wang J; Huang L; Wang Y; Baby D; Wang D; Zhang T; Qi Y; Zhang Y
Mol Plant; 2019 Jul; 12(7):1027-1036. PubMed ID: 30928637
[TBL] [Abstract][Full Text] [Related]
9. SpRY greatly expands the genome editing scope in rice with highly flexible PAM recognition.
Xu Z; Kuang Y; Ren B; Yan D; Yan F; Spetz C; Sun W; Wang G; Zhou X; Zhou H
Genome Biol; 2021 Jan; 22(1):6. PubMed ID: 33397431
[TBL] [Abstract][Full Text] [Related]
10. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
[TBL] [Abstract][Full Text] [Related]
11. Can SpRY recognize any PAM in human cells?
Ye J; Xi H; Chen Y; Chen Q; Lu X; Lv J; Chen Y; Gu F; Zhao J
J Zhejiang Univ Sci B; 2022 May; 23(5):382-391. PubMed ID: 35557039
[TBL] [Abstract][Full Text] [Related]
12. PAM-less plant genome editing using a CRISPR-SpRY toolbox.
Ren Q; Sretenovic S; Liu S; Tang X; Huang L; He Y; Liu L; Guo Y; Zhong Z; Liu G; Cheng Y; Zheng X; Pan C; Yin D; Zhang Y; Li W; Qi L; Li C; Qi Y; Zhang Y
Nat Plants; 2021 Jan; 7(1):25-33. PubMed ID: 33398158
[TBL] [Abstract][Full Text] [Related]
13. Knock-in and precise nucleotide substitution using near-PAMless engineered Cas9 variants in Dictyostelium discoideum.
Asano Y; Yamashita K; Hasegawa A; Ogasawara T; Iriki H; Muramoto T
Sci Rep; 2021 May; 11(1):11163. PubMed ID: 34045481
[TBL] [Abstract][Full Text] [Related]
14. Highly efficient base editing with expanded targeting scope using SpCas9-NG in rabbits.
Liu Z; Shan H; Chen S; Chen M; Song Y; Lai L; Li Z
FASEB J; 2020 Jan; 34(1):588-596. PubMed ID: 31914687
[TBL] [Abstract][Full Text] [Related]
15. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
[TBL] [Abstract][Full Text] [Related]
16. Genome editing in plants by engineered CRISPR-Cas9 recognizing NG PAM.
Endo M; Mikami M; Endo A; Kaya H; Itoh T; Nishimasu H; Nureki O; Toki S
Nat Plants; 2019 Jan; 5(1):14-17. PubMed ID: 30531939
[TBL] [Abstract][Full Text] [Related]
17. SpRY: Engineered CRISPR/Cas9 Harnesses New Genome-Editing Power.
Zhang D; Zhang B
Trends Genet; 2020 Aug; 36(8):546-548. PubMed ID: 32456805
[TBL] [Abstract][Full Text] [Related]
18. High-throughput analysis of the activities of xCas9, SpCas9-NG and SpCas9 at matched and mismatched target sequences in human cells.
Kim HK; Lee S; Kim Y; Park J; Min S; Choi JW; Huang TP; Yoon S; Liu DR; Kim HH
Nat Biomed Eng; 2020 Jan; 4(1):111-124. PubMed ID: 31937939
[TBL] [Abstract][Full Text] [Related]
19. Continuous evolution of SpCas9 variants compatible with non-G PAMs.
Miller SM; Wang T; Randolph PB; Arbab M; Shen MW; Huang TP; Matuszek Z; Newby GA; Rees HA; Liu DR
Nat Biotechnol; 2020 Apr; 38(4):471-481. PubMed ID: 32042170
[TBL] [Abstract][Full Text] [Related]
20. Gene editing of Duchenne muscular dystrophy using biomineralization-based spCas9 variant nanoparticles.
Li S; Du M; Deng J; Deng G; Li J; Song Z; Han H
Acta Biomater; 2022 Dec; 154():597-607. PubMed ID: 36243370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
